Get the latest delivered to your inbox
Privacy Policy

Now Reading

Merck is Collaborating To Help Make Cancer Care More Accessible Worldwide

How we’re advancing health equity through partnerships to help patients navigate cancer care

Merck is Collaborating To Help Make Cancer Care More Accessible Worldwide

How we’re advancing health equity through partnerships to help patients navigate cancer care

Published 06-19-23

Submitted by Merck & Co., Inc.

A patient talking to a medical provider.

In underserved and under-resourced communities across the globe, from the U.S. to Rwanda, our company is helping patients at risk for and living with cancer access the care they need to stay well and lead fulfilling lives.

We have a global-to-local approach, where we support programs and initiatives that help advance health equity directly in communities around the world by addressing barriers that people may face when accessing high-quality, equitable health care.

Advancing patient-centered cancer care in every community

Our company collaborates with the American Cancer Society (ACS) to address high disparities in cancer care. In the U.S, we partnered with ACS on its Get Screened Initiative, which encourages people to schedule regular cancer screening tests. Through this initiative:

~497K vulnerable community members enabled to be screened in 2021 and 2022 combined

~11,200 incidences of breast, cervical and colorectal cancer found

We’re also helping the ACS bring its expertise in patient navigation to resource-limited settings in sub-Saharan Africa as well as develop a toolkit to help low- and middle-income countries adopt navigation programs as part of delivering comprehensive cancer care.

Our global partnerships at work

In addition, we’ve partnered with City Cancer Challenge to implement a Patient Navigation Program in Kigali, Rwanda. With our support, City Cancer Challenge has trained nurses to become patient navigators. They help patients understand health information more easily, identify and assess cancer care gaps and barriers, help to accelerate the path to health care options, and mitigate the risk of patients falling out of the care continuum.

Olivier Habimana, a cancer patient navigator with City Cancer Challenge, said he witnessed first-hand how this program has given his team the ability to effectively communicate, share and exchange information so that vital data can be used for the benefit of cancer patients.

“Before the implementation of this project, patients faced all sorts of challenges. If they were referred to a hospital for cancer care, sometimes they’d go to the wrong hospital, while others missed their follow-up visits.”

- Olivier Habimana

The Patient Navigation Program has created an impact in the east African country:

1,220+ patients supported by the program

Building on our legacy for high-quality, equitable care now and in the future

We continue to forge new partnerships to help reach underserved and under-resourced communities. This includes:

  • Partnering to improve access to cancer care to under-served communities in Georgia.
  • Supporting solutions like MedHaul that can help to address transportation barriers to accessing care.
  • Providing access to educational and advocacy resources on the unique challenges faced by Black women 
    diagnosed with triple-negative breast cancer (TNBC).
  • Working with Go Further, a partnership that aims to reduce cervical cancer incidence in HIV positive women in eight African countries with the highest rates of HIV prevalence and cervical cancer deaths in the world.

“Building on our foundational principles of innovation and putting patients first, we’re committed to discovering new ways of enabling access to high-quality, equitable cancer care,” said Carmen Villar, vice president of social business innovation. “I couldn’t be more proud to be one of many in this effort.”

Learn more about Merck’s Environmental, Social & Governance (ESG) approach by visiting

View original content here

Merck & Co., Inc. Logo

Merck & Co., Inc.

Merck & Co., Inc.

At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit and connect with us on TwitterFacebookInstagramYouTube and LinkedIn.

More from Merck & Co., Inc.

Join today and get the latest delivered to your inbox